0001225208-22-003940.txt : 20220302
0001225208-22-003940.hdr.sgml : 20220302
20220302200740
ACCESSION NUMBER: 0001225208-22-003940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220228
FILED AS OF DATE: 20220302
DATE AS OF CHANGE: 20220302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WISEMAN ERIC C
CENTRAL INDEX KEY: 0001237851
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38769
FILM NUMBER: 22706186
MAIL ADDRESS:
STREET 1: 319 MEADOWBROOK TERRACE
CITY: GREENSBORO
STATE: NC
ZIP: 27408
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cigna Corp
CENTRAL INDEX KEY: 0001739940
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 824991898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
BUSINESS PHONE: 8602266000
MAIL ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
FORMER COMPANY:
FORMER CONFORMED NAME: Halfmoon Parent, Inc.
DATE OF NAME CHANGE: 20180508
4
1
doc4.xml
X0306
4
2022-02-28
0001739940
Cigna Corp
CI
0001237851
WISEMAN ERIC C
900 COTTAGE GROVE ROAD
BLOOMFIELD
CT
06002
1
Common Stock, $.01 Par Value
2022-02-28
4
A
0
199.0000
0.0000
A
20459.0000
D
Phantom Stock Units
2022-02-28
4
A
0
192.0000
237.7800
A
Common Stock, $.01 Par Value
192.0000
6404.0000
D
Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.
Includes 28 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferred Compensation Plan for Directors of Cigna Corporation.
By: Jill M. Stadelman, attorney-in-fact
2022-03-02